EUDA Health to Implement 1-for-20 Reverse Stock Split Effective March 23

The latest update is out from EUDA Health Holdings ( (EUDA) ).

On March 19, 2026, EUDA Health Holdings’ board approved a 1-for-20 reverse stock split of its ordinary shares, with trading on a split-adjusted basis on Nasdaq set to begin on March 23, 2026 under the existing EUDA ticker. The move reduces the number of outstanding ordinary shares from about 50.3 million to roughly 2.5 million while leaving shareholders’ proportional ownership and voting power largely unchanged apart from minor rounding effects.

The company will not issue fractional shares or pay cash in lieu, instead rounding holdings up to the nearest whole share, and it will also adjust its outstanding warrants so that the share coverage falls from about 4.46 million to roughly 223,000 and the exercise price rises from $11.50 to $230.00. The reverse split, handled operationally by transfer agent Equiniti, is expected to support EUDA’s share price and Nasdaq compliance while leaving the fundamental rights and privileges of ordinary shareholders substantially intact.

The most recent analyst rating on (EUDA) stock is a Buy with a $2.75 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.

More about EUDA Health Holdings

EUDA Health Holdings is a Singapore-based non-invasive and preventive healthcare provider operating across Singapore, Malaysia and China, with an additional property management business in Singapore. The company targets the fast-growing longevity segment, aiming to serve the evolving needs of an aging regional population of more than 1.8 billion people through accessible, science-backed health solutions.

Average Trading Volume: 564,984

Technical Sentiment Signal: Sell

Current Market Cap: $17.77M

For detailed information about EUDA stock, go to TipRanks’ Stock Analysis page.